Following the dividend increase, the dividend has risen from EUR 1.05 for the 2012 financial year to EUR 3.60 since the company’s IPO. The dividend yield is 3.5 percent, based on the average share price in 2025 of EUR 104.34. For financial year 2026, the Board of Management is aiming for a dividend of more than EUR 4.00 per share.

In addition, the Talanx Group is maintaining its international focus, with shareholders approving the change in Talanx AG's legal form to a Societas Europaea (SE). The move reflects the importance of the Group’s international business and implementation is expected by the end of 2026, subject to the completion of an employee involvement procedure.

At the Annual General Meeting, Talanx AG’s Chairman of the Board of Management, Torsten Leue, highlighted the Group’s extremely strong performance last year: “Thanks to our operating strength and the tailwind from a positive claims experience, we both generated record Group net income in 2025 and further increased our net income quality. We have continued to strengthen our balance sheet with our asset management policy and by enhancing our resilience. Our strategy – which is based on diversification, decentralisation, cost leadership and a culture of trust – has proved its worth yet again, including for our investors. At EUR 3.60, the dividend has increased by 33 percent – once again outstripping the rise in Group net income – and we have kept our promise to deliver continuous dividend growth. And our successful performance is continuing: we have started 2026 with a new record for quarterly net income of EUR 774 million.”

The Annual General Meeting elected three new shareholder representatives – Dr Annette Beller, Martin Peters and Stephan Ruoff – to the Supervisory Board of Talanx AG. Dr Herrman Jung, Dirk Lohmann and Nobert Steiner stepped down from the Supervisory Board.

Dr Annette Beller has built up extensive financial and industrial expertise during her long tenure as CFO at B. Braun.

Martin Peters has many years of experience in managing large industrial companies. He has been managing the family-owned Eberspächer Group as a managing partner since 2001.

Stephan Ruoff has many years of experience working for financial services providers and reinsurers; he currently holds a management position at Schroders Capital.

“On behalf of the entire Supervisory Board, I would like to extend my warmest thanks to Dr Jung, Mr Lohmann and Mr Steiner for their long-standing, trusting and extremely successful collaboration over the past years. All three have been closely associated with the Talanx Group as members of the Supervisory Board since 2013. At the same time, I look forward to working with Dr Beller, Mr Peters and Mr Ruoff in the future,” said Herbert K. Haas, Chairman of the Supervisory Board of Talanx AG.

A total of 91.3 percent of the company's voting share capital was represented at the Annual General Meeting in the Hannover Congress Centrum.

Talanx AG’s next General Meeting is scheduled to take place on 5 May 2027.